Article
Nosocomial acute gastroenteritis outbreak caused by an equine-like G3P[8] DS-1-like rotavirus and GII.4 Sydney[P16] norovirus at a pediatric hospital in Rio de Janeiro, Brazil, 2019
Registro en:
GUTIERREZ, Meylin B. et al. Nosocomial acute gastroenteritis outbreak caused by an equine-like G3P[8] DS-1-like rotavirus and GII.4 Sydney[P16] norovirus at a pediatric hospital in Rio de Janeiro, Brazil, 2019. Human Vaccines & Immunotherapeutics, v. 17, n. 11, p. 4654-4660, 2021.
2164-554X
10.1080/21645515.2021.1963169
Autor
Gutierrez, Meylin B.
Figueiredo, Mirza Rocha de
Fialho, Alexandre Madi
Cantelli, Carina Pacheco
Miagostovich, Marize Pereira
Fumian, Tulio Machado
Resumen
Worldwide, rotavirus (RVA) and norovirus are considered major etiological agents of acute gastroenteritis
(AGE) in pediatric population admitted to hospitals. This study describes the investigation of nosocomial
infections caused by emergent RVA and norovirus strains reported at a pediatric hospital in southern Brazil
in May 2019. This outbreak affected 30 people among children and adults. Nine stool samples (eight
children and one nurse) were obtained and analyzed by RT-qPCR to detect and quantify RVA and
norovirus. Positive samples were genotyped by sequencing and subjected to phylogenetic analysis. We
detected RVA in 44.4% (4/9) and norovirus in 55.5% (5/9) at high viral loads, ranging from 3.5 × 107 to
6.1 × 107 and 3.2 × 102 to 3.2 × 109 genome copies/g of stool, respectively. Co-infections were not
observed. RVA VP4 and VP7 gene sequencing in combination with polyacrylamide gel electrophoresis
identified the circulation of equine-like G3P[8] DS-1-like, and the partial sequencing of the other nine
genes revealed that strains possessed I2-R2-C2-M2-A2-N1-T2-E2-H2 genotype background. The emergent
recombinant norovirus variant, GII.4 Sydney[P16], was identified by ORF1-2 sequencing. Active surveillance
and effective prevention measures should be constantly reinforced to avoid the spread of nosocomial
viral infections into hospitals, which could severely affect pediatric patients admitted with underlying
health conditions.